These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 5699093
1. Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999). Somani P, Watson DL. J Pharmacol Exp Ther; 1968 Dec; 164(2):317-25. PubMed ID: 5699093 [No Abstract] [Full Text] [Related]
2. Influence of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999) on ventricular fibrillation induced by coronary occlusion. Kaumann AJ, Aramendia P. Acta Physiol Lat Am; 1966 Dec; 16(2):206-7. PubMed ID: 5918592 [No Abstract] [Full Text] [Related]
3. Mechanism of action of adrenergic beta-receptor blocking agents in the prevention of cyclopropane adrenaline-evoked ventricular arrhythmias in the dog. Sharma PL, Narang RS. Indian J Med Res; 1968 Aug; 56(8):1256-64. PubMed ID: 5711605 [No Abstract] [Full Text] [Related]
4. Antiarrhythmic properties of MJ 9067 in acute animal models. Byrne JE, Gomoll AW, McKinney GR. J Pharmacol Exp Ther; 1977 Jan; 200(1):147-54. PubMed ID: 401883 [Abstract] [Full Text] [Related]
6. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation. Laddu R. Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344 [No Abstract] [Full Text] [Related]
7. Effects of interaction of antiarrhythmic drugs and beta-blocking agents on the isolated rabbit heart. Bertaccini G, Impicciatore M, Visioli O, Malagnino G. Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):209-17. PubMed ID: 5709785 [No Abstract] [Full Text] [Related]
8. Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors. Wilkenfeld BE, Levy B. Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):218-32. PubMed ID: 5709786 [No Abstract] [Full Text] [Related]
9. Propranolol (Inderal) in experimentally-induced cardiac arrhythmias. Lucchesi BR, Whitsitt LS, Brown NL. Can J Physiol Pharmacol; 1966 Jul; 44(4):543-7. PubMed ID: 5966564 [No Abstract] [Full Text] [Related]
11. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog. Wellens D, Wauters E. Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391 [No Abstract] [Full Text] [Related]
12. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999). Aramendía P, Kaumann AJ. J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517 [No Abstract] [Full Text] [Related]
13. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763). Somani P. Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851 [No Abstract] [Full Text] [Related]
14. The effect of propranolol and the dextro and laevo isomers of H 56-28 upon ouabain-induced ventricular tachycardia in unanaesthetized dogs. Duce BR, Garberg L, Johansson B. Acta Pharmacol Toxicol (Copenh); 1967 Jan; 25():41-9. PubMed ID: 6072571 [No Abstract] [Full Text] [Related]